168 related articles for article (PubMed ID: 17409041)
1. Successful resurfacing of scars from previous deliberate self-harm using Integra dermal matrix substitute.
Ismail A; Jarvi K; Canal AC
J Plast Reconstr Aesthet Surg; 2008 Jul; 61(7):839-41. PubMed ID: 17409041
[TBL] [Abstract][Full Text] [Related]
2. An objective long-term evaluation of Integra (a dermal skin substitute) and split thickness skin grafts, in acute burns and reconstructive surgery.
Nguyen DQ; Potokar TS; Price P
Burns; 2010 Feb; 36(1):23-8. PubMed ID: 19864070
[TBL] [Abstract][Full Text] [Related]
3. [Role of skin substitutes in surgical repair of the sequelae of burn injuries].
Dantzer E
Ann Chir Plast Esthet; 2011 Oct; 56(5):369-81. PubMed ID: 21924807
[TBL] [Abstract][Full Text] [Related]
4. Bioartificial dermal substitute: a preliminary report on its use for the management of complex combat-related soft tissue wounds.
Helgeson MD; Potter BK; Evans KN; Shawen SB
J Orthop Trauma; 2007 Jul; 21(6):394-9. PubMed ID: 17620998
[TBL] [Abstract][Full Text] [Related]
5. The use of a bilaminate artificial skin substitute (Integra) in acute resurfacing of burns: an early experience.
Fitton AR; Drew P; Dickson WA
Br J Plast Surg; 2001 Apr; 54(3):208-12. PubMed ID: 11254411
[TBL] [Abstract][Full Text] [Related]
6. Use of Integra® dermal substitute in the treatment of complex wounds caused by antiblastic extravasation injury.
Onesti MG; Dessy LA; Fino P; Scuderi N
J Plast Reconstr Aesthet Surg; 2011 Feb; 64(2):e57-9. PubMed ID: 20864422
[No Abstract] [Full Text] [Related]
7. Use of an artificial dermis (Integra) for the reconstruction of extensive burn scars in children. About 22 grafts.
Groos N; Guillot M; Zilliox R; Braye FM
Eur J Pediatr Surg; 2005 Jun; 15(3):187-92. PubMed ID: 15999312
[TBL] [Abstract][Full Text] [Related]
8. Integra artificial skin in use for full-thickness burn surgery: benefits or harms on patient outcome.
Fette A
Technol Health Care; 2005; 13(6):463-8. PubMed ID: 16340090
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of acneiform scarring with CO2 ablative fractional resurfacing.
Chapas AM; Brightman L; Sukal S; Hale E; Daniel D; Bernstein LJ; Geronemus RG
Lasers Surg Med; 2008 Aug; 40(6):381-6. PubMed ID: 18649382
[TBL] [Abstract][Full Text] [Related]
10. A preliminary investigation of the reinnervation and return of sensory function in burn patients treated with INTEGRA®.
Anderson JR; Fear MW; Phillips JK; Dawson LF; Wallace H; Wood FM; Rea SM
Burns; 2011 Nov; 37(7):1101-8. PubMed ID: 21543157
[TBL] [Abstract][Full Text] [Related]
11. The use of a non-cultured autologous cell suspension and Integra dermal regeneration template to repair full-thickness skin wounds in a porcine model: a one-step process.
Wood FM; Stoner ML; Fowler BV; Fear MW
Burns; 2007 Sep; 33(6):693-700. PubMed ID: 17485177
[TBL] [Abstract][Full Text] [Related]
12. Objective evaluation of the efficacy of a non-ablative fractional 1565 nm laser for the treatment of deliberate self-harm scars.
Guertler A; Reinholz M; Poetschke J; Steckmeier S; Schwaiger H; Gauglitz GG
Lasers Med Sci; 2018 Feb; 33(2):241-250. PubMed ID: 29080008
[TBL] [Abstract][Full Text] [Related]
13. The use of Integra in necrotizing fasciitis.
Akhtar S; Hasham S; Abela C; Phipps AR
Burns; 2006 Mar; 32(2):251-4. PubMed ID: 16446035
[No Abstract] [Full Text] [Related]
14. Integra--a therapeutic alternative in reconstructive surgery. Our first experience.
Popescu S; Ghetu N; Grosu O; Nastasa M; Pieptu D
Chirurgia (Bucur); 2007; 102(2):197-204. PubMed ID: 17615922
[TBL] [Abstract][Full Text] [Related]
15. Correlation of clinical outcome of integra application with microbiologic and pathological biopsies.
Muangman P; Deubner H; Honari S; Heimbach DM; Engrav LH; Klein MB; Gibran NS
J Trauma; 2006 Nov; 61(5):1212-7. PubMed ID: 17099531
[TBL] [Abstract][Full Text] [Related]
16. Our first experience with Integra.
Tymonová J; Adámková M; Klosová H; Kadlcík M; Zámecníková I
Acta Chir Plast; 2005; 47(1):5-9. PubMed ID: 15954454
[TBL] [Abstract][Full Text] [Related]
17. Use of Integra in a paediatric upper extremity degloving injury.
Herlin C; Louhaem D; Bigorre M; Dimeglio A; Captier G
J Hand Surg Eur Vol; 2007 Apr; 32(2):179-84. PubMed ID: 17224224
[TBL] [Abstract][Full Text] [Related]
18. Changes in the plasma cytokine and growth factor profile are associated with impaired healing in pediatric patients treated with INTEGRA® for reconstructive procedures.
Nessler M; Puchala J; Wood FM; Wallace HJ; Fear MW; Nessler K; Drukala J
Burns; 2013 Jun; 39(4):667-73. PubMed ID: 23031827
[TBL] [Abstract][Full Text] [Related]
19. [The use of Integra dermal regeneration matrix in the surgical treatment of a recurrent, extensive, malignant skin lesion in the temporal region].
Halmy C; Nádai Z; Csőre K; Vajda A; Tamás R
Orv Hetil; 2013 Feb; 154(6):225-7. PubMed ID: 23376690
[TBL] [Abstract][Full Text] [Related]
20. Dermal substitute (Integra) for open nasal wounds.
Thornton JF; Rohrich RJ
Plast Reconstr Surg; 2005 Aug; 116(2):677. PubMed ID: 16079720
[No Abstract] [Full Text] [Related]
[Next] [New Search]
